TMO

662.24

0.64% 4.22

시간 외 거래: 662.03 -0.21 -0.03%

써모 피셔 사이언티픽 (TMO)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측 주식 분할 배당 이력

전일 마감가:

$658.02

열려 있는:

$657.23

하루 거래량:

1.37M

Relative Volume:

0.67

시가총액:

$244.86B

수익:

$45.20B

순이익/손실:

$6.87B

주가수익비율:

36.41

EPS:

18.1888

순현금흐름:

$6.75B

1주 성능:

-2.15%

1개월 성능:

+8.60%

6개월 성능:

+33.49%

1년 성능:

+26.19%

1일 변동 폭

$652.50

$662.54

1주일 범위

$635.32

$694.33

52주 변동 폭

$435.27

$694.33

써모 피셔 사이언티픽 Stock (TMO) Company Profile

명칭

Thermo Fisher Scientific Inc

부문

Healthcare (1051)

산업

Diagnostics & Research (44)

전화

(781) 622-1000

주소

168 THIRD AVENUE, WALTHAM, MA

직원

125,000

트위터

@thermofisher

다음 수익 날짜

2026-10-21

최신 SEC 제출 서류

TMO's Discussions on Twitter

Compare TMO vs DHR, NTRA, A, IQV

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
TMO Thermo Fisher Scientific Inc	662.24	244.86B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	221.20	155.50B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	397.77	57.34B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	171.33	48.30B	7.23B	1.41B	1.09B	4.979
IQV Iqvia Holdings Inc	262.21	43.16B	16.63B	1.39B	2.12B	8.0674

써모 피셔 사이언티픽 Stock (TMO) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-09-09	업그레이드	UBS	Neutral → Buy
2026-09-03	개시	CLSA	Outperform
2026-06-26	재개	Bernstein	Mkt Perform
2026-06-11	개시	Piper Sandler	Neutral
2026-06-03	다운그레이드	HSBC Securities	Buy → Hold
2026-06-02	재개	Wolfe Research	Outperform
2026-05-15	재개	RBC Capital Mkts	Sector Perform
2026-03-27	개시	DZ Bank	Buy
2025-12-11	업그레이드	Citigroup	Neutral → Buy
2025-12-09	개시	Goldman	Buy
2025-12-08	업그레이드	KeyBanc Capital Markets	Sector Weight → Overweight
2025-12-02	재개	Morgan Stanley	Overweight
2025-12-01	업그레이드	HSBC Securities	Hold → Buy
2025-09-11	업그레이드	Barclays	Equal Weight → Overweight
2025-08-19	개시	William Blair	Outperform
2025-07-24	다운그레이드	HSBC Securities	Buy → Hold
2025-07-11	업그레이드	Scotiabank	Sector Perform → Sector Outperform
2025-07-09	다운그레이드	UBS	Buy → Neutral
2025-01-10	업그레이드	Bernstein	Mkt Perform → Outperform
2024-12-23	개시	Scotiabank	Sector Perform
2024-10-14	개시	Redburn Atlantic	Buy
2024-10-01	개시	Stephens	Overweight
2024-08-28	개시	Wells Fargo	Overweight
2024-06-03	재개	Jefferies	Buy
2024-03-18	재개	Citigroup	Neutral
2024-01-24	다운그레이드	Barclays	Overweight → Equal Weight
2024-01-08	다운그레이드	Bernstein	Outperform → Mkt Perform
2023-12-18	개시	HSBC Securities	Buy
2023-12-13	개시	Wolfe Research	Outperform
2023-10-26	다운그레이드	KeyBanc Capital Markets	Overweight → Sector Weight
2023-10-25	업그레이드	Wells Fargo	Underweight → Equal Weight
2023-09-28	개시	Bernstein	Outperform
2023-09-06	재개	Citigroup	Buy
2023-07-19	개시	Raymond James	Outperform
2023-07-19	재확인	Robert W. Baird	Outperform
2023-07-13	업그레이드	Credit Suisse	Neutral → Outperform
2023-04-04	재확인	Barclays	Overweight
2022-12-14	개시	Deutsche Bank	Buy
2022-12-07	개시	RBC Capital Mkts	Outperform
2022-10-27	다운그레이드	The Benchmark Company	Buy → Hold
2022-08-25	개시	Credit Suisse	Neutral
2022-04-25	다운그레이드	Wells Fargo	Equal Weight → Underweight
2022-01-26	재개	Barclays	Overweight
2021-10-20	업그레이드	Citigroup	Neutral → Buy
2021-10-15	재개	Cowen	Outperform
2021-08-05	재개	Credit Suisse	Outperform
2021-07-16	개시	The Benchmark Company	Buy
2021-03-18	업그레이드	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-03	개시	Barclays	Overweight
2021-01-08	업그레이드	Credit Suisse	Neutral → Outperform
2020-12-16	다운그레이드	Citigroup	Buy → Neutral
2020-12-02	개시	Goldman	Buy
2020-11-10	개시	KeyBanc Capital Markets	Sector Weight
2020-09-30	개시	Atlantic Equities	Overweight
2020-09-14	개시	Morgan Stanley	Overweight
2020-08-20	재개	JP Morgan	Overweight
2020-07-15	업그레이드	Cleveland Research	Neutral → Buy
2020-07-07	재확인	Needham	Buy
2020-04-23	재확인	Needham	Buy
2020-01-31	재확인	Needham	Buy
2020-01-22	개시	Credit Suisse	Neutral
2020-01-08	개시	Wells Fargo	Equal Weight
2020-01-07	개시	Citigroup	Buy
2019-11-15	개시	Stifel	Buy
2019-07-25	재확인	Needham	Buy
2019-07-16	다운그레이드	Needham	Strong Buy → Buy
2019-05-30	개시	Wolfe Research	Outperform
2019-05-23	재확인	Needham	Strong Buy
2019-04-22	재확인	Needham	Strong Buy
2019-04-16	재확인	BofA/Merrill	Buy

모두보기

써모 피셔 사이언티픽 주식(TMO)의 최신 뉴스

09:41 AM

Thermo Fisher Scientific stock trades at EUR 587.70, volume is 4.1 percent of average - ad-hoc-news.de

09:41 AM

09:10 AM

Morgan Stanley Adjusts Price Target on Thermo Fisher Scientific to $730 From $650 - marketscreener.com

09:10 AM

05:09 AM

BofA raises Thermo Fisher target to USD 745 from USD 650 for Thermo Fisher Scientific stock - ad-hoc-news.de

05:09 AM

01:34 AM

Thermo Fisher Scientific stock pre-market at EUR 587.40 - ad-hoc-news.de

01:34 AM

Oct 09, 2026

Thermo Fisher Scientific Inc Stock 12‑Month Price Target Raised to $682.12, Implies 5% Upside - TradingView

Oct 09, 2026

Thermo Fisher Scientific's Q3 2026 Earnings: What to Expect - Barchart.com

Oct 09, 2026

Global Decentralized Clinical Trials Market Size, Trends, and Forecast, 2025-2030 | AI, Wearables, and Cloud-Based Platforms Fuel 13.7% CAGR to $18.8 Billion - GlobeNewswire Inc.

Oct 09, 2026

Oct 08, 2026

Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch

Oct 08, 2026

What Could Thermo Fisher Scientific (TMO) Change With Its New Digital CMC Consortium? - Yahoo Finance

Oct 08, 2026

Why Thermo Fisher Scientific (TMO) Is Back In The Spotlight - Yahoo Finance

Oct 08, 2026

Oct 07, 2026

Thermo Fisher Scientific Inc. (1TMO.MI) stock price, news, quote and history - Yahoo Finance UK

Oct 07, 2026

Thermo Fisher Scientific Inc. (1TMO.MI) Stock Price, News, Quote & History - Yahoo! Finance Canada

Oct 07, 2026

Is This the Right Time to Add TMO Stock to Your Portfolio? - Zacks Investment Research

Oct 07, 2026

Oct 06, 2026

Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market - MarketWatch

Oct 06, 2026

JPMorgan Adds AmEx, Thermo Fisher and Liberty Energy to October Overweight Picks - BigGo Finance

Oct 06, 2026

Thermo Fisher Scientific stock heads into October 21 results after a 2.27 percent drop - AD HOC NEWS

Oct 06, 2026

Thermo Fisher Scientific (TMO): Strong Q3 Guidance and Broadening Demand Support Multi-Year Outlook - Yahoo Finance

Oct 06, 2026

Barclays Adjusts Thermo Fisher Scientific Price Target to $750 From $650, Maintains Overweight Rating - marketscreener.com

Oct 06, 2026

Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis - GlobeNewswire Inc.

Oct 06, 2026

Preparations begin for Quantum BioPharma's planned Phase 2 multiple sclerosis drug trial - Stock Titan

Oct 06, 2026

Exclusive: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial - Benzinga

Oct 06, 2026

Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026 - BioSpace

Oct 06, 2026

Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.

Oct 06, 2026

Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026 - Business Wire

Oct 06, 2026

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific - Zacks Investment Research

Oct 06, 2026

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific - TradingView

Oct 06, 2026

Oct 05, 2026

Thermo Fisher Scientific Inc (TMO) Stock Up 3.4% but GF Value Sa - GuruFocus

Oct 05, 2026

Thermo Fisher Scientific Inc Stock (TMO) Closed Up by 3.35% on Oct 5: Key Drivers Unveiled - TradingKey

Oct 05, 2026

Thermo Fisher Scientific accelerates market access by prioritizing the right KOLs - MedTech Dive

Oct 05, 2026

Here’s How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years - Benzinga

Oct 05, 2026

Thermo Fisher Scientific Proteomics Technologies Enable Discovery of More Than 2,500 New Biological Associations in PRECISE-SG100K Study - Business Wire

Oct 05, 2026

Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in Focus - Zacks Investment Research

Oct 05, 2026

Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.

Oct 05, 2026

Global Oligonucleotide Synthesis Reagents Market Size, Share, and Forecast, 2026-2033 | Therapeutics Demand Fuels 11.9% CAGR and USD 1.75 Billion Opportunity - GlobeNewswire Inc.

Oct 05, 2026

Cell and Gene Therapy Biomanufacturing MarketSize, Share, and Forecast, 2026-2031 | Automation, Viral Vectors, and CDMO Expansion Drive 11.7% CAGR to $8.7 Billion - GlobeNewswire Inc.

Oct 05, 2026

Magnetic Beads MarketGlobal Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 Billion - GlobeNewswire Inc.

Oct 05, 2026

Global Methyl Grignard Reagent MarketStrategic Forecast, 2026-2032 | Pharmaceutical Demand, AI Process Control, and Resilient Supply Chains Unlock Growth Opportunities - GlobeNewswire Inc.

Oct 05, 2026

Oct 04, 2026

Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch

Oct 01, 2026

Thermo Fisher Scientific Inc Stock (TMO) Closed Down by 3.34% on Oct 1: What Signal Does It Send? - tradingkey.com

Oct 01, 2026

Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.

Oct 01, 2026

Continuous Bioprocessing Technologies MarketGlobal Forecast 2026-2031 | Market to Reach USD 8.5 Billion as Automation and Biologics Demand Fuel 12.1% CAGR - GlobeNewswire Inc.

Oct 01, 2026

Should CHO K1 Media Launch Require Action From Thermo Fisher Scientific Stock Investors? - Simply Wall Street

Oct 01, 2026

Sep 30, 2026

Thermo Fisher Scientific Inc (TMO) Stock Forecasts - Yahoo Finance

Sep 30, 2026

North America Non-Viral Transfection Reagents Market Forecast to 2035 | Cell and Gene Therapy Demand Drives 8.5% CAGR and a USD 0.70 Billion Opportunity - GlobeNewswire Inc.

Sep 30, 2026

Sep 29, 2026

Thermo Fisher Scientific Inc (TMO) Stock Up 0.1% but GF Value Sa - gurufocus.com

Sep 29, 2026

Thermo Fisher (TMO) director's deferred stock units total 2,846.55 after a quarterly credit - Stock Titan

Sep 29, 2026

At $675 per unit, a Thermo Fisher (TMO) director was credited with 62.96 stock units. - Stock Titan

Sep 29, 2026